Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury. - Wikidata - wikimedia - TriplyDB

Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury.

Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury.

http://www.wikidata.org/entity/Q33646877

about

Emerging Functions of Natural IgM and Its Fc Receptor FCMR in Immune Homeostasis Complement in the Homeostatic and Ischemic Brain The endothelial deprotection hypothesis for lupus pathogenesis: the dual role of C1q as a mediator of clearance and regulator of endothelial permeability C1 esterase inhibitor reduces lower extremity ischemia/reperfusion injury and associated lung damage.Deficiency of complement receptors CR2/CR1 in Cr2⁻/⁻ mice reduces the extent of secondary brain damage after closed head injury.Antigenicity of Bovine Pericardium Determined by a Novel Immunoproteomic Approach Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement Membrane lipid interactions in intestinal ischemia/reperfusion-induced Injury CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent Oxidative stress sensitizes retinal pigmented epithelial (RPE) cells to complement-mediated injury in a natural antibody-, lectin pathway-, and phospholipid epitope-dependent manner.TLR2 modulates antibodies required for intestinal ischemia/reperfusion-induced damage and inflammation Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury Pathogenic natural antibodies propagate cerebral injury following ischemic stroke in mice.Challenging the role of adaptive immunity in neurotrauma: Rag1(-/-) mice lacking mature B and T cells do not show neuroprotection after closed head injury.The steroid and xenobiotic receptor negatively regulates B-1 cell development in the fetal liver.The Fifth Domain of Beta 2 Glycoprotein I Protects from Natural IgM Mediated Cardiac Ischaemia Reperfusion Injury IgM exacerbates glomerular disease progression in complement-induced glomerulopathy B-1 cells in the bone marrow are a significant source of natural IgM.Natural IgM Blockade Limits Infarct Expansion and Left Ventricular Dysfunction in a Swine Myocardial Infarct Model Human β2-glycoprotein I attenuates mouse intestinal ischemia/reperfusion induced injury and inflammation IgM contributes to glomerular injury in FSGS Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice Detection of complement activation using monoclonal antibodies against C3d.New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities.The role of the complement system in acute kidney injury.Ischemia and reperfusion--from mechanism to translation.Role of complement and perspectives for intervention in ischemia-reperfusion damage.Protective Roles of Natural IgM Antibodies.Lung ischemia reperfusion injury: a bench-to-bedside review.Mechanisms of myocardial ischemia-reperfusion injury and the cytoprotective role of minocycline: scope and limitations.Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment.Microbiota-Induced Antibodies Are Essential for Host Inflammatory Responsiveness to Sterile and Infectious Stimuli.A Special Connection between γδ T Cells and Natural Antibodies?Injury site-specific targeting of complement inhibitors for treating stroke.Accommodation and related conditions in vascularized composite allografts.CD4+ T cells and complement independently mediate graft ischemia in the rejection of mouse orthotopic tracheal transplants.PD-L2 Regulates B-1 Cell Antibody Production against Phosphorylcholine through an IL-5-Dependent Mechanism.IgM in the kidney: a multiple personality disorder.Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat.Prevention of intestinal ischemia-reperfusion injury in humanized mice.

P2860

Q26751003-5013034E-6FD9-422F-84DB-D9FF3873BBE1 Q26796057-CC07FD5F-D74B-4992-AB36-39BAAEF23A39 Q28649846-C2EBDD71-565D-4A2D-BB76-D300534EE425 Q31132259-185333B8-4651-4927-93C1-9F80020481C2 Q33729953-200FDF25-FA65-480B-BC6B-2ADE5411C9B2 Q33732798-E9625430-B5BA-4974-8FBD-CFCFFF91D25E Q33814826-C2E11D46-C556-405F-BAAC-7ECD74447957 Q33902557-999E4F80-C9CD-4361-A3C0-C1E1A143967B Q34507790-246746C4-AD4D-4EED-87B5-68F72EE1D37D Q34620560-3C18AFF8-ACD9-49A3-86D2-156A69420916 Q34980207-AF0E3415-F461-4895-BFF3-9916F966BB1C Q35246399-04D9751F-F713-4292-90B6-1EB98F365BA5 Q35685695-718733F6-F598-4BC0-B9DD-826440701856 Q35886721-93F6AA98-70E8-4B8B-9ADA-7D23346863EC Q35970050-2AE8C60B-4850-4C7E-82B6-4446878AC883 Q35974974-BF6A2BCB-521E-4E51-A893-A2D6601D6CF0 Q36016859-D1E91637-14E5-4906-A897-4E00A9DF0AD3 Q36185232-EE66CD5E-B554-4088-9101-422BDC37AFEB Q36394858-9225B0F1-B0CD-461B-96FA-D1CF6CE3ECE4 Q36590359-A6E70C66-1D4A-4F1F-8D44-D3F8E4A85A5C Q36638347-873A3ED6-4305-4D7D-9151-75A27730719B Q36718295-C3A5AE37-1B64-4836-B558-7A3A8B781638 Q36793448-D23FAB9B-D8F1-4F30-8704-6EB9CC079E2C Q37180522-3AFCD177-3607-4E85-A802-9895C4F712D7 Q37275159-C700862B-578B-4639-A55D-BEC8D42EC8D9 Q37455225-6AB456F2-CEB1-4EA6-AC81-D627E2E08074 Q37831329-BBF4E620-50A5-40CF-8402-4DC4BCA814B3 Q38008368-2E7E9648-308E-40F1-A301-8A569782655A Q38050047-3415DBEB-B813-4A8C-BF23-584039E05A2D Q38326656-D77A6695-8E44-4214-A7DD-4AF3C31EC451 Q38541350-F56E7887-A2D1-4923-B732-65DCC8532617 Q38829718-1F333CBF-D261-40CB-89A1-68E1F057C5C9 Q38846636-54995E94-7F93-420C-93A8-924892D5DF46 Q38991032-F4E80F38-A337-466E-9D88-CBCDD31F00CC Q39418200-C382CD33-C2E7-4DAC-913E-4F68337A105B Q39923372-2CA93864-55D6-49AD-ABF3-9F0DF0A93B19 Q40109527-0B0290A0-7993-4528-9AD8-5E8211E681DE Q41023817-4CAB28AB-614B-48EC-86EA-05C4E9EE7DC1 Q41653771-75B973D3-8886-44F8-8618-89A812644956 Q42427237-B578D12E-A616-40C6-9A23-7F614926F17A

P2860

Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury.

http://www.wikidata.org/entity/Q33646877

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Pathogenic natural antibodies ...... l ischemia-reperfusion injury.

@ast

Pathogenic natural antibodies ...... l ischemia-reperfusion injury.

@en

type

label

Pathogenic natural antibodies ...... l ischemia-reperfusion injury.

@ast

Pathogenic natural antibodies ...... l ischemia-reperfusion injury.

@en

prefLabel

Pathogenic natural antibodies ...... l ischemia-reperfusion injury.

@ast

Pathogenic natural antibodies ...... l ischemia-reperfusion injury.

@en

P1433

Q33646877-21081300-8776-495E-B2EF-56396AC2BEA6

P1476

Q33646877-7ADB2106-A662-491C-9938-C66083D2FD39

P2093

Q33646877-0A9D5E13-DFFA-4324-9290-BF4AA492E206

Q33646877-20D9DD3D-1B91-4BEC-81D1-3F7E557EF229

Q33646877-53C68D4E-965E-4603-8333-CF398FEF8B3F

Q33646877-613427F8-4E14-4AF9-935C-9E43E92A1899

Q33646877-7267D190-ABD2-4F72-BD45-1745401B4B44

Q33646877-9BC91DFB-A60F-461B-AD70-E5488C74E96C

Q33646877-9F9E6D54-405A-441F-AC0D-706A2E20F03B

Q33646877-A46FADD8-F51E-4468-88C2-2104CF6C2B92

Q33646877-AD11A3F1-4705-4A78-980F-527B5F02132F

Q33646877-B7AB0877-4400-48B0-A28A-77F01D5BAEDE

P2860

Q33646877-01FB44A9-3B9B-4C72-A86D-3131976E40D0

Q33646877-0239F0B2-5F9F-481C-BAA6-3AD08BFB4E96

Q33646877-0331F019-8D85-40D9-B642-4BD484AA997F

Q33646877-0DA40F62-44D4-40FA-A1B5-DF11EC99BE06

Q33646877-0E2E9457-881C-4A28-BC4C-1FE143961215

Q33646877-1C249880-CED0-4397-B27E-CD7CE838975A

Q33646877-1E624E37-3DAD-4EA0-BC5F-0669CE7B7C28

Q33646877-2042E97E-098B-45BD-84E9-BAA1EC87F7F1

Q33646877-24D4CCB6-CE68-4563-801D-D7B2359C1C2F

Q33646877-251F81BE-2ABC-42A6-AAE5-FA4040AD7571

P304

Q33646877-829219A9-EFAA-483B-B1F2-9BF4291E8D1F

P31

Q33646877-6F6203A7-0B91-4B64-A5B1-9301055EB205

P356

Q33646877-30200C18-B617-491D-AD05-016250F43AB8

P407

Q33646877-B498167B-5B93-4479-98E7-BAB4A69B167E

P433

Q33646877-491F573F-7B3F-46BF-BF04-7D1D549C371D

P478

Q33646877-A8AC8373-F795-4A06-8AC7-55D21AD198A9

P577

Q33646877-6B9FCCD2-A5C8-44C2-8858-BA30E81A5B7E

P5875

Q33646877-E1CBD350-3C9C-463A-8F7E-BEC10B4DDA2F

P698

Q33646877-51075BE0-F2F4-42E0-8D7B-8A3993DB256A

P921

Q33646877-3A655173-18CB-4572-8121-77B59AF6A7E0

Q33646877-43F455C6-599B-47C1-9CC5-EEA058D85B41

P932

Q33646877-1577F489-24C5-472E-979E-B6823B29E29D

P356

JIMMUNOL.0803980

P1433

Journal of Immunology

P1476

Pathogenic natural antibodies ...... l ischemia-reperfusion injury.

@en

P2093

Adam Markaryan

http://www.w3.org/2001/XMLSchema#string

Aleksey Novikov

http://www.w3.org/2001/XMLSchema#string

Chantal Moratz

http://www.w3.org/2001/XMLSchema#string

George C Tsokos

http://www.w3.org/2001/XMLSchema#string

Gregg J Silverman

http://www.w3.org/2001/XMLSchema#string

Jason W Reuter

http://www.w3.org/2001/XMLSchema#string

Kathy A Andrews

http://www.w3.org/2001/XMLSchema#string

Kuan Chen

http://www.w3.org/2001/XMLSchema#string

Liudmila Kulik

http://www.w3.org/2001/XMLSchema#string

Richard J Quigg

http://www.w3.org/2001/XMLSchema#string

P2860

Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin

Annexin A4 self-association modulates general membrane protein mobility in living cells.

B1 cells: similarities and differences with other B cell subsets

A potential endogenous ligand of annexin IV in the exocrine pancreas. Carbohydrate structure of GP-2, a glycosylphosphatidylinositol-anchored glycoprotein of zymogen granule membranes

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice

Annexin IV (Xanx-4) has a functional role in the formation of pronephric tubules

Identification of a novel protein complex containing annexin A4, rabphilin and synaptotagmin

Annexins: linking Ca2+ signalling to membrane dynamics

Ca(2+)-dependent binding of endonexin (annexin IV) to membranes: analysis of the effects of membrane lipid composition and development of a predictive model for the binding interaction.

P304

5363-5373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.0803980

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

182

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24311636

http://www.w3.org/2001/XMLSchema#string

P698

19380783

http://www.w3.org/2001/XMLSchema#string

P921

reperfusion injury

P932

2820395

http://www.w3.org/2001/XMLSchema#string